: Surged over 7% recently due to the Organon acquisition ; remains a top pick for its expanding global specialty generic portfolio.
: A top weekly pick with a 14% upside target (₹240) , supported by projected 8–10% domestic demand growth through FY30.
: Noted for a record order book of ₹24.2 billion , offering high revenue visibility despite regional geopolitical tensions.
: Recommended as a "Buy" in the ₹2,324–₹2,325 range, with a target of ₹2,470 , following a bullish breakout on daily charts.
: Attractive for its Q1 earnings and upcoming May 1 dividend record date . Blue Chip Stocks for Stability
The following stocks have been highlighted by leading brokerages like Mirae Asset ShareKhan , Motilal Oswal , and Univest for their current momentum and growth potential:
As of , the Indian stock market is showing resilience, with the Nifty 50 trading near 24,092 . Analysts are currently emphasizing "stock-specific" opportunities, particularly in sectors with strong Q4 FY26 earnings results like Pharma, Metals, and FMCG . Top Analyst Recommendations (April 2026)
: Target set at ₹267 ; analysts cite a breakout from a broad range and a bullish "Inverted Head and Shoulders" pattern.
Indian Shares To Buy Now -
: Surged over 7% recently due to the Organon acquisition ; remains a top pick for its expanding global specialty generic portfolio.
: A top weekly pick with a 14% upside target (₹240) , supported by projected 8–10% domestic demand growth through FY30.
: Noted for a record order book of ₹24.2 billion , offering high revenue visibility despite regional geopolitical tensions. indian shares to buy now
: Recommended as a "Buy" in the ₹2,324–₹2,325 range, with a target of ₹2,470 , following a bullish breakout on daily charts.
: Attractive for its Q1 earnings and upcoming May 1 dividend record date . Blue Chip Stocks for Stability : Surged over 7% recently due to the
The following stocks have been highlighted by leading brokerages like Mirae Asset ShareKhan , Motilal Oswal , and Univest for their current momentum and growth potential:
As of , the Indian stock market is showing resilience, with the Nifty 50 trading near 24,092 . Analysts are currently emphasizing "stock-specific" opportunities, particularly in sectors with strong Q4 FY26 earnings results like Pharma, Metals, and FMCG . Top Analyst Recommendations (April 2026) : Recommended as a "Buy" in the ₹2,324–₹2,325
: Target set at ₹267 ; analysts cite a breakout from a broad range and a bullish "Inverted Head and Shoulders" pattern.
A